Background: Systemic sclerosis (SSc) is characterized by fibrosis of the skin. The dermis of the skin is rich in type I and III collagen, but other collagens as type VI collagen are present in the skin and play a key role in the organization of type I and III collagen. There is a lack of objective disease activity markers in SSc for frequent assessment of patients. The only measurement of disease activity currently is the subjective modified Rodnan skin score (mRSS). Objectives: The objective is to examine blood-based markers of type I, III, and VI collagen formation as surrogates of disease activity and fibrosis in SSc. Methods: SSc patients fulfilling the ACR criteria (n=121) were included. The study included both limited SSc (lSSc, n=79) and diffuse SSc (dSSc, n=42) (approval number H-B-2008-131). Markers of type I, III and VI collagen formation (P1NP, PRO-C3 and PRO-C6, respectively) were measured in serum by ELISA. Difference in the markers between groups were tested by Mann-Whitney T test and correlations were assessed by multiple linear regression adjusting for age, Abstract SAT0317 - Table 2 Highest tertile of skin score vs rest Highest vs low tertile of skin score OR (95% CI) P-value RR (95% CI) P-value OR (95% CI) P-value RR (95% CI) P-value P1NP 1.1 (0.5-2.6) 1.1 (0.6-1.9) 2.3 (0.7-6.9) 1.6 (0. gender and BMI. Discriminative power of the markers was analyzed by ROC AUC on tertiles of mRSS.
Results: There were no significant difference in gender, BMI or disease duration between lSSc and dSSc. The mean age of the population was 57.4 (SD 11.6) years, 84% were female, mean disease duration was 11.7 (SD 8.9) years and mean mRSS was 11.2 (SD 8.6). PRO-C3 and PRO-C6 were significantly higher early (<4 years) dSSc compared to early lSSc patients (both p=0.006). PRO-C6 was significantly elevated in early dSSc compared to late dSSc (p=0.04) and increased in late dSSc compared to late lSSc (p=0.02; Figure) . Both PRO-C3 and PRO-C6 correlated with mRSS when adjusted for age, gender, and BMI with R-partial of 0.36 (p=0.0001) and 0.29 (p=0.002), respectively. Both PRO-C3, and PRO-C6 could separate the patient group having the highest tertile of mRSS from the rest with an AUC (95% CI) of 0.73 (0.62-0.82), and 0.74 (0.63-0.83), respectively. Together, PRO-C3 and PRO-C6 could separate the groups with an AUC (95% CI) of 0.77 (0.67-0.86) ( Table 1) . PRO-C3 and PRO-C6 performed equally well for identification of patients with the highest skin score (highest tertile vs. the middle and lower tertile) with a relative risk of 2.3 (1.4-3.8) ( Table 2 ). The risk of being in the highest tertile of mRSS compared to the lowest were significantly higher with a high PRO-C6 (relative risk 2.6, 95% CI: 1.3-5.2) compared to PRO-C3 (relative risk: 2.2, 95% CI: 1.2-3.8) ( Table 2) . 
